Manidipine

Manidipine is a calcium channel blocker (dihydropyridine type) that is used clinically as an antihypertensive. The substance belongs to the class of dihydropyridines and has antihypertensive properties. Manidipine is not registered for use in all countries.
Pharmacology[edit]
Manidipine is a potent vasodilator due to its strong affinity for L-type calcium channels that are present in the smooth muscle cells of the arterial wall. The blockade of these channels inhibits the influx of calcium ions, which prevents the contraction of the smooth muscle cells and leads to their relaxation. This results in a decrease in peripheral vascular resistance, leading to a decrease in blood pressure.
Clinical Use[edit]
Manidipine is used for the treatment of hypertension. It may be used alone or in combination with other antihypertensive drugs. The drug has a long duration of action that allows for once-daily dosing. Manidipine is well tolerated and has a favorable side effect profile.
Side Effects[edit]
The most common side effects of manidipine are related to its vasodilatory action and include flushing, headache, palpitations, and ankle swelling. Other side effects can include dizziness, fatigue, and nausea.
Contraindications[edit]
Manidipine is contraindicated in patients with known hypersensitivity to dihydropyridines. It should be used with caution in patients with severe cardiac insufficiency or in patients with severe hepatic impairment.
Interactions[edit]
Manidipine can interact with other drugs, such as beta-blockers, ACE inhibitors, and diuretics, which can lead to additive antihypertensive effects. It can also interact with CYP3A4 inhibitors, which can increase the plasma concentration of manidipine.
See Also[edit]
| Hypertension and related topics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Hypertension related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
